Clinical Trial Watch: Bladder Cancer; Overactive Bladder

October 1, 2011

This list of National Institutes of Health trials is derived from the NIH's database and includes phase III and IV bladder cancer trials and phase II overactive bladder trials. This list is current as of Sept. 15, 2011.

Bladder Cancer

Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer Sponsor(s): U.Z. Gasthuisberg
Identifier: NCT00729287

Quality of Life in Patients With Bladder Cancer Sponsor(s): University of Birmingham
Identifier: NCT00553215

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients Sponsor(s): Memorial Sloan-Kettering Cancer Center; New York Presbyterian Hospital; Weill Medical College of Cornell University
Identifier: NCT00974818

Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer Sponsor(s): University of Birmingham
Identifier: NCT00553566

Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Sponsor(s): Southwest Oncology Group; National Cancer Institute (NCI)
Identifier: NCT00445601